Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
| Active as of 2022-05-29 |
Resource Evidence "47751" Version "18" Updated "2023-12-06 17:47:29+0000"
Profiles: ComparativeEvidence, SingleStudyEvidence
StructureDefinition Work Group: cds
url: https://fevir.net/resources/Evidence/47751
identifier: FEvIR Object Identifier: 47751
version: 1.0.0-ballot
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Ikramuddin_2013
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Ikramuddin 2013
status: active
date: 2022-05-29 11:03:23+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
author: Brian S. Alper:
| Code | Value[x] |
| Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | ComparativeEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#ComparativeEvidence) |
| Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | SingleStudyEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#SingleStudyEvidence) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: derived-from
label: data source
display: Figure 2C
citation: Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations [Journal Article]. Contributors: Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman, Stephanie A Amiel, Lee M Kaplan, Gaspar Taroncher-Oldenburg, David E Cummings, Delegates of the 2nd Diabetes Surgery Summit. In: Diabetes care, PMID 27222544. Published June 2016. Available at: https://pubmed.ncbi.nlm.nih.gov/27222544/.
document
relatedArtifact
type: cite-as
citation: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Ikramuddin 2013 [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47751. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47751. Computable resource at: https://fevir.net/resources/Evidence/47751.
description: Mean HbA1c at 12 months in Ikramuddin 2013 was 6.3 % in Surgery group (n = 57) and 7.8% in Medical/Lifestyle group (n = 19), mean difference -1.50% (95% CI -1.95% to -1.05%)
variableDefinition
VariableDefinitionVariableRoleCode: population
description: 114 patients with T2DM and BMI 30 to 39.9 and HbA1c >= 8.0
note: population
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#population "population")
observed: : Ikramuddin 2013 Trial Enrollment Group
variableDefinition
VariableDefinitionVariableRoleCode: exposure
VariableDefinitionComparatorCategory: Lifestyle-intensive medical management intervention based on the Diabetes Prevention Program and LookAHEAD trials for 2 years
description: Roux-en-Y Gastric Bypass vs. medical treatment (Lifestyle-intensive medical management intervention LS/IMM)
note: exposure
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#exposure "exposure")
observed: EvidenceVariable/172481: GroupAssignment: Roux-en-Y gastric bypass surgery vs. Lifestyle-intensive medical management intervention alone "GroupAssignment_Roux_en_Y_gastric_bypass_surgery_vs_Lifestyle_intensive_medical_management_intervention_alone"
variableDefinition
VariableDefinitionVariableRoleCode: outcome
description: HbA1c at 12 months
note: outcome
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#measuredVariable "measured variable")
observed: EvidenceVariable/173243: OutcomeVariable: HbA1c at 12 months "OutcomeVariable_HbA1c_at_12_months"
synthesisType: not applicable (StatisticSynthesisType#NotApplicable)
studyDesign: randomized assignment (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#SEVCO:01003)
statistic
description: mean difference -1.50% (95% CI -1.95% to -1.05%)
note: Mean HbA1c at 12 months in Ikramuddin 2013 was 6.3 % in Surgery group (n = 57) and 7.8% in Medical/Lifestyle group (n = 57)
statisticType: Mean Difference (StatisticStatisticType#0000457)
quantity: -1.5 % (Details: UCUM code % = '%')
SampleSizes
NumberOfParticipants KnownDataCount 114 114 AttributeEstimates
Description Type Level Range 95% CI -1.95% to -1.05% Confidence interval (StatisticAttribute Estimate Type#C53324) 0.95 -1.95--1.05 %
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change